US2018028755A1PendingUtilityA1

Connected health platform including needle-free injector system

Assignee: PORTAL INSTR INCPriority: Jul 28, 2016Filed: Dec 2, 2016Published: Feb 1, 2018
Est. expiryJul 28, 2036(~10 yrs left)· nominal 20-yr term from priority
G16H 40/60G16H 30/40A61M 2205/3584A61M 2205/3331A61M 5/30A61M 2205/3368
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A needle-free injector system includes a needle-free injector having at least one sensor configured to detect, using the at least one sensor, a degree to which a patient has administered a treatment using the needle-free injector, and configured to transmit information to a server regarding the administration of the treatment; and the server configured to communicate, to a device associated with the patient, a message regarding the administration of the treatment. A method of determining patient compliance with a treatment regimen includes detecting a potential treatment event by a needle-free injector system; measuring, using at least one sensor proximal to a treatment site on a body of a patient, at least one physical parameter; and determining, using the measurement of the at least one physical parameter, a level of compliance of the patient for the potential treatment event.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A needle-free injector system comprising:
 a needle-free injector having at least one sensor configured to detect, using the at least one sensor, at least one physical parameter at a treatment site on a body of a patient, the at least one physical parameter indicative of a degree to which a patient has administered a treatment using the needle-free injector, and configured to transmit information to a server regarding the administration of the treatment; and   the server configured to receive, for a plurality of treatment events over a period of time, a degree to which the patient has administered the plurality of treatment events, to determine a compliance rate for a treatment regimen of the patient for the plurality of treatment events, and to communicate, to a device associated with the patient, a message regarding the administration of at least one of the plurality of treatment events.   
     
     
         2 . The system of  claim 1 , wherein the device associated with the patient is at least one of a mobile device, a computer, a display terminal, and a television. 
     
     
         3 . The system of  claim 1 , wherein the device associated with the patient is a device of an individual other than the patient. 
     
     
         4 . The system of  claim 1 , wherein the message is a reminder regarding the treatment. 
     
     
         5 . The system of  claim 1 , wherein the message is a question relating to at least one of the treatment, the patient's well-being, and the user's health, wherein the server is further configured to receive, from the device associated with the patient, a response to the at least one question. 
     
     
         6 . The system of  claim 1 , wherein the message is stimulation for the patient to administer the treatment. 
     
     
         7 . The system of  claim 1 , wherein the needle-free injector is configured to be communicatively coupled to a disposable device preloaded with a dose of a drug. 
     
     
         8 . The system of  claim 1 , wherein the needle-free injector comprises:
 a handheld injector; and   a base unit communicatively coupled to the handheld injector and to the server.   
     
     
         9 . The system of  claim 1 , wherein the needle-free injector further comprises a temperature conditioning element configured to change a temperature of a drug dose administered in the treatment. 
     
     
         10 . The system of  claim 1 , wherein the at least one sensor comprises at least one of a pressure sensor, a capacitive sensor, an accelerometer, a gyroscope, and a thermometer. 
     
     
         11 . The system of  claim 10 , wherein the needle-free injector determines, from the gyroscope, that the needle-free injector is oriented in a suitable direction prior to administering the treatment. 
     
     
         12 . The system of  claim 1 , wherein the needle-free injector further comprises at least one second sensor configured to detect an ambient condition proximal to the needle-free injector. 
     
     
         13 . The system of  claim 12 , wherein the ambient condition is an amount of atmospheric moisture. 
     
     
         14 . The system of  claim 1 , further comprising a network interface configured to communicate with a third party system associated with at least one of a healthcare professional, a pharmacy, an insurer, and a treatment supplier, wherein the server is configured to communicate, to the third party system, information regarding the patient's compliance in administering the treatment. 
     
     
         15 . The system of  claim 1 , further comprising a network interface configured to communicate with a third party system associated with a supplier of the needle-free injector, wherein the server is configured to communicate, to the third party system, information regarding performance of the needle-free injector. 
     
     
         16 . The system of  claim 1 , wherein the needle-free injector further comprises a network interface and is configured to receive, via the network interface, information from at least one computer application associated with the patient. 
     
     
         17 . The system of  claim 16 , wherein the information from the at least one computer application includes at least one of activity information, diet information, weight information, and physiological information. 
     
     
         18 . (canceled) 
     
     
         19 . The system of  claim 1 , wherein the server is further configured to determine a target level of compliance of the patient for the plurality of treatment events, and modify a parameter of a subsequent treatment event based on the level of compliance and the target level of compliance. 
     
     
         20 . The system of  claim 19 , wherein the target level of compliance correlates to an enhanced outcome for a condition being treated by the treatment event. 
     
     
         21 . The system of  claim 1 , wherein the at least one sensor monitors a physical parameter associated with an administration of the treatment. 
     
     
         22 . The system of  claim 21 , wherein the needle-free injector is further configured to determine, using the at least one sensor, a first measurement of a physical parameter of a treatment site on a body of the patient prior to the treatment. 
     
     
         23 . The system of  claim 22 , wherein the needle-free injector is further configured to determine, using the at least one sensor, a second measurement of the physical parameter of the treatment site on the body of the patient subsequent to the treatment.

Join the waitlist — get patent alerts

Track US2018028755A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.